BioBots is a company that exemplifies how 3D printing will be instrumental to the future of healthcare. While there are new filaments popping up every day that can be used for the purpose of 3D printing, BioBots' $5,000 machine specializes in printing functional living tissue.
As well as having a huge impact for people in need of transplants, BioBots' technology could also transform drug research by removing the need for animal testing. On YouTube, BioBots has already demonstrated how its machines can print a set of human ears from tissue from a patient's own cells.
By introducing a way to totally eliminate the organ wait list, it's no wonder that BioBots was named the Most Innovative Company at this year's SXSW Accelerator Awards.
Biological Cell Printers
BioBots' Medical 3D Printing Machine Creates Functional Living Tissue
Trend Themes
1. 3D Printing in Healthcare - BioBots' medical 3D printing machine creates functional living tissue, revolutionizing healthcare by enabling efficient organ transplantation and drug research without the need for animal testing.
2. Elimination of Organ Wait List - BioBots' technology has the potential to completely eliminate the organ wait list by producing functional living tissue for transplantation, providing disruptive innovation opportunities in the healthcare industry.
3. Replacement of Animal Testing - BioBots' 3D printing technology can replace the need for animal testing in drug research, opening up possibilities for more ethical and efficient testing methods.
Industry Implications
1. Healthcare - The use of BioBots' medical 3D printing machine can revolutionize the healthcare industry by enabling efficient organ transplantation and drug research without the need for animal testing.
2. Biotechnology - BioBots' technology has disruptive innovation potential in the biotechnology industry by providing a more sustainable and ethical approach to tissue engineering and drug development.
3. Medical Device Manufacturing - The development of BioBots' 3D printers could disrupt the medical device manufacturing industry by enabling the production of functional living tissue for transplantation and research purposes.